Trump’s international drug pricing plan is nearly upon us

One of President Trump’s long-promised — and, in pharma, long-feared — ideas on drug pricing will soon see the light of day.

As Bloomberg reports, Trump is planning to give a major speech next month in which he’ll outline a plan for an international pricing index, a system that would peg what Medicare pays for certain drugs to their prices overseas.

It’s an idea that could have vast implications on drug companies that rely on Medicare for sizable portions of their revenue. Industry share prices slumped earlier this year when Trump first brought up the notion but recovered last month when the Senate advanced a pricing bill that made no mention of an international index.